Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Lago

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 19, 2019
Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: A Systematic ReviewMaria Manuela Estevinho, Cátia Rocha, Luís Correia, et al.
Journal of Crohn'S & Colitis|September 8, 2020
Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-AnalysisFernando Magro, Maria Manuela Estevinho, Cláudia Camila Dias, et al.
Autopsy & Case Reports|May 10, 2021
A rare cecal subepithelial tumor in a Crohn´s Disease patientJoana Inês Alves da Silva, Cidalina Caetano, Anabela Maria Sousa da Rocha, et al.
Clinical and Translational Gastroenterology|March 29, 2022
Incidence Trends of Inflammatory Bowel Disease in a Southern European Country: A Mirror of the Western World?Mafalda Santiago, Francisco Stocker, Paula Ministro, et al.
Inflammatory Bowel Diseases|January 9, 2020
Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel DiseasePedro Pinto-Lopes, Joana Afonso, Rui Pinto-Lopes, et al.
Clinical and Translational Gastroenterology|February 15, 2021
Age at Diagnosis Is Determinant for the Outcome of Inflammatory Bowel Disease: Is It a Myth?Paula Ministro, Cláudia Camila Dias, Francisco Portela, et al.
Journal of Crohn'S & Colitis|October 18, 2018
Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes-Bayesian Network AnalysisFernando Magro, Cláudia Camila Dias, Francisco Portela, et al.
Inflammatory Bowel Diseases|December 1, 2021
Bringing to Light the Risk of Colorectal Cancer in Inflammatory Bowel Disease: Mucosal Glycosylation as a Key PlayerEduarda Leite-Gomes, Ana M Dias, Catarina M Azevedo, et al.
Therapeutic Advances in Gastroenterology|December 7, 2020
Rapid test detection of anti-infliximab antibodies: performance comparison with three different immunoassaysCátia Rocha, Paula Lago, Samuel Fernandes, et al.
Journal of Crohn'S & Colitis|September 22, 2018
A [Glyco]biomarker that Predicts Failure to Standard Therapy in Ulcerative Colitis PatientsMárcia S Pereira, Luís Maia, Luís F Azevedo, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 19, 2019
Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: A Systematic ReviewMaria Manuela Estevinho, Cátia Rocha, Luís Correia, et al.
Journal of Crohn'S & Colitis|September 8, 2020
Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-AnalysisFernando Magro, Maria Manuela Estevinho, Cláudia Camila Dias, et al.
Autopsy & Case Reports|May 10, 2021
A rare cecal subepithelial tumor in a Crohn´s Disease patientJoana Inês Alves da Silva, Cidalina Caetano, Anabela Maria Sousa da Rocha, et al.
Clinical and Translational Gastroenterology|March 29, 2022
Incidence Trends of Inflammatory Bowel Disease in a Southern European Country: A Mirror of the Western World?Mafalda Santiago, Francisco Stocker, Paula Ministro, et al.
Inflammatory Bowel Diseases|January 9, 2020
Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel DiseasePedro Pinto-Lopes, Joana Afonso, Rui Pinto-Lopes, et al.
Clinical and Translational Gastroenterology|February 15, 2021
Age at Diagnosis Is Determinant for the Outcome of Inflammatory Bowel Disease: Is It a Myth?Paula Ministro, Cláudia Camila Dias, Francisco Portela, et al.
Journal of Crohn'S & Colitis|October 18, 2018
Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes-Bayesian Network AnalysisFernando Magro, Cláudia Camila Dias, Francisco Portela, et al.
Inflammatory Bowel Diseases|December 1, 2021
Bringing to Light the Risk of Colorectal Cancer in Inflammatory Bowel Disease: Mucosal Glycosylation as a Key PlayerEduarda Leite-Gomes, Ana M Dias, Catarina M Azevedo, et al.
Therapeutic Advances in Gastroenterology|December 7, 2020
Rapid test detection of anti-infliximab antibodies: performance comparison with three different immunoassaysCátia Rocha, Paula Lago, Samuel Fernandes, et al.
Journal of Crohn'S & Colitis|September 22, 2018
A [Glyco]biomarker that Predicts Failure to Standard Therapy in Ulcerative Colitis PatientsMárcia S Pereira, Luís Maia, Luís F Azevedo, et al.
Pageof 9